Evidence map›Paper›PMID 28387654›Full record

ArticleAntiviral therapy2017

Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.

Catherine A Hankins, Sinata Koulla-Shiro, Peter Kilmarx, Guido Ferrari, Mauro Schechter, Coumba Touré Kane, François Venter, Charles Ab Boucher, Anna-Laura Ross, Debrework Zewdie and 2 more

Abstract readConference Proceedings
In one paragraph

Article in Antiviral therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Catherine A HankinsAmsterdam Institute for Global Health and Development (AIGHD), Department of Global Health, University of Amsterdam, Amsterdam, the Netherlands.
Sinata Koulla-ShiroMinistry of Health, Yaoundé, Cameroon.
Peter KilmarxNational Institutes of Health, Fogarty International Center, Bethesda, MD, USA.
Guido FerrariDuke University Medical Center, Department of Surgery, Durham, NC, USA.
Mauro SchechterFederal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Coumba Touré KaneLaboratoire de Bacteriologie-Virologie CHU Le Dantec, Dakar University, Dakar, Senegal.
François VenterWits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
Charles Ab BoucherErasmus Medical Center, Department of Viroscience, Rotterdam, the Netherlands.
Anna-Laura RossNational Agency for AIDS Research (ANRS), Paris, France.
Debrework ZewdieCUNY School of Public Health and Public Policy, New York, NY, USA.
Serge Paul EholiéCHU de Treichville, University of Abidjan, Abidjan, Ivory Coast.
Elly KatabiraMakarere University College of Health Sciences in Kampala, Kampala, Uganda.

Funding

10th INTEREST Workshop on HIVR13AI125032 · NIAID · DUKE UNIVERSITY · PI FERRARI, GUIDO · 2016 to 2016
$70k
NIAID NIH HHS R13 AI125032
6 · The paper itself

Abstract

The underpinning theme of the 2016 INTEREST Conference held in Yaoundé, Cameroon, 3-6 May 2016 was ending AIDS as a public health threat by 2030. Focused primarily on HIV treatment, pathogenesis and prevention research in resource-limited settings, the conference attracted 369 active delegates from 34 countries, of which 22 were in Africa. Presentations on treatment optimization, acquired drug resistance, care of children and adolescents, laboratory monitoring and diagnostics, implementation challenges, HIV prevention, key populations, vaccine and cure, hepatitis C, mHealth, financing the HIV response and emerging pathogens, were accompanied by oral, mini-oral and poster presentations. Spirited plenary debates on the UNAIDS 90-90-90 treatment cascade goal and on antiretroviral pre-exposure prophylaxis took place. Joep Lange career guidance sessions and grantspersonship sessions attracted early career researchers. At the closing ceremony, the Yaoundé Declaration called on African governments; UNAIDS; development, bilateral, and multilateral partners; and civil society to adopt urgent and sustained approaches to end HIV by 2030.

Indexed as

Pre-Exposure ProphylaxisAcquired Immunodeficiency SyndromeAdolescentAdultAIDS VaccinesAnti-HIV AgentsCameroonChildDisease EradicationForecastingHumansInternational CooperationPublic HealthAIDS VaccinesAnti-HIV Agents

Identifiers

PMID28387654
PMCPMC5542813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.